Plus Therapeutics Inc (PSTV)
1.23
+0.05
(+4.24%)
USD |
NASDAQ |
Jan 03, 16:00
1.22
-0.01
(-0.81%)
After-Hours: 20:00
Plus Therapeutics SG&A Expense (Quarterly): 2.397M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
Perspective Therapeutics Inc | 6.975M |
Retractable Technologies Inc | 4.946M |
InfuSystems Holdings Inc | 15.53M |
Xtant Medical Holdings Inc | 19.38M |
Catheter Precision Inc | 2.882M |